For pharmaceutic companies it is very hard today to be innovative. New drug development costs tremendously large amounts of investment and there is no guarantee for market release. Neither is there a foresight of customer acceptence or unwanted side effects. Innovation thus has to be established in more than the classical way of developing drugs and flood the market. Modern synergies, fast adopting and individual partnerships can (asside merger and acquisitions) offer a wide range of symbiotic options to move forward in innovation and customer services, in efficiency and return of investment. 

Dr. Alexander Biedermann has been in the field of Business Develpment and Innovation for many years now. He always has been an embassador for fresh and innovative ways to lift up the traditional business. Always staying very close on the demands of the customer. His visionary mind and his sparkling ideas have already enabled him to identify business options long before the market was visible to customers.